Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
November 12, 2024 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis TIDES Europe Presentations to Feature Next Step in Evolution of Enzymatic Synthesis for RNAi Therapeutics
November 11, 2024 16:05 ET
|
Codexis, Inc.
—Spotlight Presentation to showcase four routes of synthesis of an approved siRNA therapeutic asset— —Joint poster presentation with Bachem to compare Codexis double-stranded RNA ligase to wild-type...
Codexis Announces New Employment Inducement Grants
November 08, 2024 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis to Participate in Upcoming Healthcare Conferences
November 04, 2024 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis Reports Third Quarter 2024 Financial Results
October 31, 2024 16:05 ET
|
Codexis, Inc.
Quarter Highlights Include Key Additions to Management Team and Extension of Cash Runway into 2027 with $31M Raise via ATM Facility Company Reiterates Full-year Financial Guidance; On Track to...
Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting
October 24, 2024 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis Announces New Employment Inducement Grants
October 14, 2024 07:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis to Report Third Quarter 2024 Financial Results on October 31
October 10, 2024 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company
October 02, 2024 16:05 ET
|
Codexis, Inc.
Company raises $31 million through ATM, bringing cash runway into 2027 New additions to leadership in technical operations, finance and intellectual property prepare Codexis for the next phase of...
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
October 01, 2024 07:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into a non-exclusive commercial and...